These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 27183527)
1. Preventing antiblastic drug-related cardiomyopathy: old and new therapeutic strategies. Cadeddu C; Mercurio V; Spallarossa P; Nodari S; Triggiani M; Monte I; Piras R; Madonna R; Pagliaro P; Tocchetti CG; Mercuro G J Cardiovasc Med (Hagerstown); 2016 May; 17 Suppl 1():S64-75. PubMed ID: 27183527 [TBL] [Abstract][Full Text] [Related]
2. Preventing antiblastic drug-related cardiomyopathy: old and new therapeutic strategies. Cadeddu C; Mercurio V; Spallarossa P; Nodari S; Triggiani M; Monte I; Piras R; Madonna R; Pagliaro P; Tocchetti CG; Mercuro G J Cardiovasc Med (Hagerstown); 2016 May; 17 Suppl 1 Special issue on Cardiotoxicity from Antiblastic Drugs and Cardioprotection():e64-e75. PubMed ID: 27755244 [TBL] [Abstract][Full Text] [Related]
3. Pathophysiology of anthracycline cardiotoxicity. Mele D; Tocchetti CG; Pagliaro P; Madonna R; Novo G; Pepe A; Zito C; Maurea N; Spallarossa P J Cardiovasc Med (Hagerstown); 2016 May; 17 Suppl 1():S3-S11. PubMed ID: 27183523 [TBL] [Abstract][Full Text] [Related]
4. Chemotherapy-induced cardiotoxicity: new insights into mechanisms, monitoring, and prevention. Cadeddu Dessalvi C; Deidda M; Mele D; Bassareo PP; Esposito R; Santoro C; Lembo M; Galderisi M; Mercuro G J Cardiovasc Med (Hagerstown); 2018 Jul; 19(7):315-323. PubMed ID: 29708912 [TBL] [Abstract][Full Text] [Related]
5. Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management. Curigliano G; Cardinale D; Dent S; Criscitiello C; Aseyev O; Lenihan D; Cipolla CM CA Cancer J Clin; 2016 Jul; 66(4):309-25. PubMed ID: 26919165 [TBL] [Abstract][Full Text] [Related]
13. A recommended practical approach to the management of anthracycline-based chemotherapy cardiotoxicity: an opinion paper of the working group on drug cardiotoxicity and cardioprotection, Italian Society of Cardiology. Spallarossa P; Maurea N; Cadeddu C; Madonna R; Mele D; Monte I; Novo G; Pagliaro P; Pepe A; Tocchetti CG; Zito C; Mercuro G J Cardiovasc Med (Hagerstown); 2016 May; 17 Suppl 1(Suppl 1):S84-92. PubMed ID: 27183529 [TBL] [Abstract][Full Text] [Related]
14. Anticancer drugs and cardiotoxicity: Insights and perspectives in the era of targeted therapy. Raschi E; Vasina V; Ursino MG; Boriani G; Martoni A; De Ponti F Pharmacol Ther; 2010 Feb; 125(2):196-218. PubMed ID: 19874849 [TBL] [Abstract][Full Text] [Related]
15. Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention. Albini A; Pennesi G; Donatelli F; Cammarota R; De Flora S; Noonan DM J Natl Cancer Inst; 2010 Jan; 102(1):14-25. PubMed ID: 20007921 [TBL] [Abstract][Full Text] [Related]
16. Curing Cancer, Saving the Heart: A Challenge That Cardioncology Should Not Miss. Cardinale D; Biasillo G; Cipolla CM Curr Cardiol Rep; 2016 Jun; 18(6):51. PubMed ID: 27108361 [TBL] [Abstract][Full Text] [Related]
18. Pathophysiology of cardiotoxicity from target therapy and angiogenesis inhibitors. Maurea N; Coppola C; Piscopo G; Galletta F; Riccio G; Esposito E; De Lorenzo C; De Laurentiis M; Spallarossa P; Mercuro G J Cardiovasc Med (Hagerstown); 2016 May; 17 Suppl 1():S19-26. PubMed ID: 27183521 [TBL] [Abstract][Full Text] [Related]
19. The Role of the Metabolism of Anticancer Drugs in Their Induced-Cardiotoxicity. Reis-Mendes AF; Sousa E; de Lourdes Bastos M; Costa VM Curr Drug Metab; 2015; 17(1):75-90. PubMed ID: 26526839 [TBL] [Abstract][Full Text] [Related]
20. The importance of drug metabolites synthesis: the case-study of cardiotoxic anticancer drugs. Hrynchak I; Sousa E; Pinto M; Costa VM Drug Metab Rev; 2017 May; 49(2):158-196. PubMed ID: 28393622 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]